l carnitine tmao koeth 2013 nature medicine Revisiting the Role of in Heart Disease Through the Lens of the Gut Microbiota γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Gut microbiota metabolism of l carnitine and cardiovascular risk Atherosclerosis Frontiers Impacts of intestinal microbiota metabolite trimethylamine N oxide on cardiovascular disease: a bibliometric analysis Trimethylamine N Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet Journal of Renal Nutrition Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect
Pay in 4 interest-free payments of $6.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





